Effects of verapamil combinations with enalapril or indapamide on plasma, vascular and platelet hemostasis and biochemical markers of endothelial dysfunction in patients with arterial hypertension and metabolic syndrome
The combination of verapamil retard and enalapril, or verapamil retard and indapamide SR similarly and significantly increased high-density lipoprotein cholesterol and stable NO2 metabolite levels, reducing platelet aggregation in patients with metabolic syndrome (MS). Compared to the combination of...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2008-06-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1572 |
| _version_ | 1797857235446005760 |
|---|---|
| author | N. M. Krasnova T. P. Kalashnikova A. I. Vengerovsky E. M. Idrisova I. V. Kulagina T. E. Suslova O. V. Gruzdeva S. V. Kremeno N. M. Zheltonogova A. A. Shishkina R. S. Karpov |
| author_facet | N. M. Krasnova T. P. Kalashnikova A. I. Vengerovsky E. M. Idrisova I. V. Kulagina T. E. Suslova O. V. Gruzdeva S. V. Kremeno N. M. Zheltonogova A. A. Shishkina R. S. Karpov |
| author_sort | N. M. Krasnova |
| collection | DOAJ |
| description | The combination of verapamil retard and enalapril, or verapamil retard and indapamide SR similarly and significantly increased high-density lipoprotein cholesterol and stable NO2 metabolite levels, reducing platelet aggregation in patients with metabolic syndrome (MS). Compared to the combination of verapamil retard and indapamide SR, the combination of verapamil retard and enalapril significantly reduced atherogenicity coefficient, glycated hemoglobin, glucose and soluble fibrin-monomer complex levels, increasing nitrite concentration and activating plasminogen. |
| first_indexed | 2024-04-09T20:53:23Z |
| format | Article |
| id | doaj.art-9e6fe648cdf64d249e81f9bdf98ebe16 |
| institution | Directory Open Access Journal |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| last_indexed | 2024-04-09T20:53:23Z |
| publishDate | 2008-06-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj.art-9e6fe648cdf64d249e81f9bdf98ebe162023-03-29T21:23:15Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202008-06-010349541351Effects of verapamil combinations with enalapril or indapamide on plasma, vascular and platelet hemostasis and biochemical markers of endothelial dysfunction in patients with arterial hypertension and metabolic syndromeN. M. Krasnova0T. P. Kalashnikova1A. I. Vengerovsky2E. M. Idrisova3I. V. Kulagina4T. E. Suslova5O. V. Gruzdeva6S. V. Kremeno7N. M. Zheltonogova8A. A. Shishkina9R. S. Karpov10Сибирский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитиюСибирский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитиюСибирский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитиюСибирский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитиюНИИ кардиологии Томского научного центра Сибирского отделения РАМННИИ кардиологии Томского научного центра Сибирского отделения РАМННИИ кардиологии Томского научного центра Сибирского отделения РАМННИИ кардиологии Томского научного центра Сибирского отделения РАМННИИ кардиологии Томского научного центра Сибирского отделения РАМНСибирский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитиюНИИ кардиологии Томского научного центра Сибирского отделения РАМНThe combination of verapamil retard and enalapril, or verapamil retard and indapamide SR similarly and significantly increased high-density lipoprotein cholesterol and stable NO2 metabolite levels, reducing platelet aggregation in patients with metabolic syndrome (MS). Compared to the combination of verapamil retard and indapamide SR, the combination of verapamil retard and enalapril significantly reduced atherogenicity coefficient, glycated hemoglobin, glucose and soluble fibrin-monomer complex levels, increasing nitrite concentration and activating plasminogen.https://russjcardiol.elpub.ru/jour/article/view/1572metabolic syndromearterial hypertensionplatelet aggregationwillebrand factorno2verapamilenalaprilindapamide |
| spellingShingle | N. M. Krasnova T. P. Kalashnikova A. I. Vengerovsky E. M. Idrisova I. V. Kulagina T. E. Suslova O. V. Gruzdeva S. V. Kremeno N. M. Zheltonogova A. A. Shishkina R. S. Karpov Effects of verapamil combinations with enalapril or indapamide on plasma, vascular and platelet hemostasis and biochemical markers of endothelial dysfunction in patients with arterial hypertension and metabolic syndrome Российский кардиологический журнал metabolic syndrome arterial hypertension platelet aggregation willebrand factor no2 verapamil enalapril indapamide |
| title | Effects of verapamil combinations with enalapril or indapamide on plasma, vascular and platelet hemostasis and biochemical markers of endothelial dysfunction in patients with arterial hypertension and metabolic syndrome |
| title_full | Effects of verapamil combinations with enalapril or indapamide on plasma, vascular and platelet hemostasis and biochemical markers of endothelial dysfunction in patients with arterial hypertension and metabolic syndrome |
| title_fullStr | Effects of verapamil combinations with enalapril or indapamide on plasma, vascular and platelet hemostasis and biochemical markers of endothelial dysfunction in patients with arterial hypertension and metabolic syndrome |
| title_full_unstemmed | Effects of verapamil combinations with enalapril or indapamide on plasma, vascular and platelet hemostasis and biochemical markers of endothelial dysfunction in patients with arterial hypertension and metabolic syndrome |
| title_short | Effects of verapamil combinations with enalapril or indapamide on plasma, vascular and platelet hemostasis and biochemical markers of endothelial dysfunction in patients with arterial hypertension and metabolic syndrome |
| title_sort | effects of verapamil combinations with enalapril or indapamide on plasma vascular and platelet hemostasis and biochemical markers of endothelial dysfunction in patients with arterial hypertension and metabolic syndrome |
| topic | metabolic syndrome arterial hypertension platelet aggregation willebrand factor no2 verapamil enalapril indapamide |
| url | https://russjcardiol.elpub.ru/jour/article/view/1572 |
| work_keys_str_mv | AT nmkrasnova effectsofverapamilcombinationswithenalaprilorindapamideonplasmavascularandplatelethemostasisandbiochemicalmarkersofendothelialdysfunctioninpatientswitharterialhypertensionandmetabolicsyndrome AT tpkalashnikova effectsofverapamilcombinationswithenalaprilorindapamideonplasmavascularandplatelethemostasisandbiochemicalmarkersofendothelialdysfunctioninpatientswitharterialhypertensionandmetabolicsyndrome AT aivengerovsky effectsofverapamilcombinationswithenalaprilorindapamideonplasmavascularandplatelethemostasisandbiochemicalmarkersofendothelialdysfunctioninpatientswitharterialhypertensionandmetabolicsyndrome AT emidrisova effectsofverapamilcombinationswithenalaprilorindapamideonplasmavascularandplatelethemostasisandbiochemicalmarkersofendothelialdysfunctioninpatientswitharterialhypertensionandmetabolicsyndrome AT ivkulagina effectsofverapamilcombinationswithenalaprilorindapamideonplasmavascularandplatelethemostasisandbiochemicalmarkersofendothelialdysfunctioninpatientswitharterialhypertensionandmetabolicsyndrome AT tesuslova effectsofverapamilcombinationswithenalaprilorindapamideonplasmavascularandplatelethemostasisandbiochemicalmarkersofendothelialdysfunctioninpatientswitharterialhypertensionandmetabolicsyndrome AT ovgruzdeva effectsofverapamilcombinationswithenalaprilorindapamideonplasmavascularandplatelethemostasisandbiochemicalmarkersofendothelialdysfunctioninpatientswitharterialhypertensionandmetabolicsyndrome AT svkremeno effectsofverapamilcombinationswithenalaprilorindapamideonplasmavascularandplatelethemostasisandbiochemicalmarkersofendothelialdysfunctioninpatientswitharterialhypertensionandmetabolicsyndrome AT nmzheltonogova effectsofverapamilcombinationswithenalaprilorindapamideonplasmavascularandplatelethemostasisandbiochemicalmarkersofendothelialdysfunctioninpatientswitharterialhypertensionandmetabolicsyndrome AT aashishkina effectsofverapamilcombinationswithenalaprilorindapamideonplasmavascularandplatelethemostasisandbiochemicalmarkersofendothelialdysfunctioninpatientswitharterialhypertensionandmetabolicsyndrome AT rskarpov effectsofverapamilcombinationswithenalaprilorindapamideonplasmavascularandplatelethemostasisandbiochemicalmarkersofendothelialdysfunctioninpatientswitharterialhypertensionandmetabolicsyndrome |